Even as biomedical researchers generate and dig through mountains of gene sequence data, physicians proceed in the clinic as they always have. They design preventive care, plan treatments and select drugs by assessing patient type-frequently with race and ethnicity central. Molecular biologists often look to these categories, too, as a means to sort out the ways in which gene variants influence patient response to drugs and disease. And if they get federal funding, investigators must divide the groups they study by race.
展开▼
